Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07071415 · ClinicalTrials.gov registry record · NA
Overdiagnosis and Breast Cancer Screening Decisions
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 311
- Enrollment target
NCT07071415: Completed NA study, sponsored by Yale University.
NCT07071415 is a NA study that has completed, run by Yale University. The registered enrollment target is 311 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07071415, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 311 participants
- Enrollment target
Study Summary
This is a survey-based study using an online panel. The goal of the study is to understand whether information about overdiagnosis influences breast cancer screening intention among older women. Participants are first asked a series of questions about breast cancer screening including their intention to continue screening, knowledge of screening, and beliefs about screening. They are then shown one of three videos about breast cancer screening that contain information about overdiagnosis or a fourth control video that is identical but contains no information about overdiagnosis. Participants are then again asked about screening intention, along with knowledge of screening, overdiagnosis, and questions around trust.
Primary Outcome
Intention to screen, measured on a 15 point scale. Total score range 1-15, lower score means less likely to screen.
Interventions
- OTHER Control condition
- BEHAVIORAL Breast cancer screening decision aid -- low risk
- BEHAVIORAL Breast cancer decision aid -- moderate risk
- BEHAVIORAL Breast cancer screening decision aid -- high risk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 311 participants |
| Start Date | 2025-08-19 |
| Est. Completion | 2025-10-20 |
| Phase | NA |
What the finished NCT07071415 record still lists
NCT07071415 is an interventional study that assigns participants to a tested intervention. The registered 311 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 4 interventions - of which Control condition is the first listed.
NCT07071415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07071415 about?
NCT07071415 is a clinical study titled "Overdiagnosis and Breast Cancer Screening Decisions". This is a survey-based study using an online panel. The goal of the study is to understand whether information about overdiagnosis influences breast cancer screening intention among older women. Participants are first asked a series of questions about breast cancer screening including their intentio...
What is the current status of trial NCT07071415?
This trial is currently completed. It is a NA study. The enrollment target is 311 participants. The study started on 2025-08-19. Estimated completion is 2025-10-20.
What interventions are being tested in trial NCT07071415?
The interventions under investigation include: Control condition (OTHER), Breast cancer screening decision aid -- low risk (BEHAVIORAL), Breast cancer decision aid -- moderate risk (BEHAVIORAL), Breast cancer screening decision aid -- high risk (BEHAVIORAL).
Who is sponsoring clinical trial NCT07071415?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07071415's enrollment target sits among peer trials
311 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI